Treatment of tobacco dependence in people with mental health and addictive disorders

Current Psychiatry Reports

Volumn 14, Issue 5, 2012, Pages 478-485

  MacKowick, Kristen M ^a,b   Lynch, Marie Josee ^c,d   Weinberger, Andrea H ^e,f   George, Tony P ^c,d,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE CANCER CENTER   (United States)

Author keywords

Alcoholism; Anxiety disorders; Comorbidities; Integrated care; Mental health and addictive disorders; Mood disorders; Nicotine dependence; Pharmacotherapy; Psychiatric disorders; Schizophrenia; Smoking cessation; Substance use disorders; Tobacco; Treatment

Indexed keywords

AMFEBUTAMONE; NEUROLEPTIC AGENT; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; OLANZAPINE; PLACEBO; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VARENICLINE;

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; BIPOLAR DISORDER; COCAINE DEPENDENCE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; GROUP THERAPY; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; MORTALITY; MOTIVATION; MULTICENTER STUDY (TOPIC); NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION;

COMBINED MODALITY THERAPY; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; MENTAL DISORDERS; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84870853780     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0299-2     Document Type: Article

References (76)

1. Giovino GA. The tobacco epidemic in the United States. Am J Prev Med. 2007;33:318-26.
2. Center for Disease Control. CDC. Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR. 2008;57:1226-8.
3. Schroeder SA, Warner KE. Don't forget tobacco. N Engl J Med. 2010;363:201-4.
4. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. J Am Med Assoc. 2000;284:2606-10.
5. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107-15. (Pubitemid 39463411)
6. Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry. 2009;54:368-78.
7. Tidey JW, Rosenhow DJ, Kaplan GB, Swift RM. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob Res. 2005;7:421-9. (Pubitemid 41418715)
8. Brown S, Inskip H, Barraclough B. Causes of excess mortality in schizophrenia. Br J Psychiatry. 2000;177:212-7.
9. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risk of cardiovascular disease. Am Heart J. 2005;150:1115-21. (Pubitemid 41773510)
10. Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Prev Med. 1994;2:61-9. (Pubitemid 24125917)
11. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment. role of tobacco use in a communitybased cohort. JAMA. 1996;275:1097-103. (Pubitemid 26106974)
12. Morisano D, Bacher I, Audrain-McGovern J, George TP. Mechanisms underlying the co-morbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry. 2009;54:356-67.
13. Wing VC, Wass CE, Soh DW, George TP. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann NY Acad Sci. 2012;1248:89-106.
14. Lo S, Heishman SJ, Raley H, et al. Tobacco craving in smokers with and without schizophrenia. Schizophr Res. 2011;127:241-5.
15. Montoya ID, Herbeck DM, Svikis DS, et al. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am J Addict. 2005;14:441-54. (Pubitemid 43372027)
16. Berk M, Ng F, Wang WV, et al. 2008: going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. J Affect Disord. 2008;110:126-34.
17. Desai HD, Seabolt J, Jann MW. Smoking inpatients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15:469-94. (Pubitemid 32601905)
18. Weinberger AH, Reutenauer EL, Allen TM, et al. Reliability of the Fagerstrom test for nicotine dependence, Minnesota nicotine withdrawal scale, and Tiffany questionnaire for smoking urges in smokers with and without schizophrenia. Drug Alcohol Depend. 2007;86:278-82. (Pubitemid 44821602)
19. Kelly DL, Raley HG, Lo S, et al. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophr Bull. 2012;38:543-51.
20. Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull. 1997;23:247-54. (Pubitemid 27224877)
21. Addington J, El-Guebaly N, Campbell W, et al. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry. 1998;155:974-6. (Pubitemid 28307615)
22. George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000;157:1835-42.
23. Baker A, Richmond R, Haile M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry. 2006;163:1934-42. (Pubitemid 44807785)
24. Evins AE, Cather C, Culhane MA, et al. A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007;27:380-6. (Pubitemid 47075510)
25. George TP, Vessicchio JC, Sacco KA, et al. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry. 2008;63:1092-6.
26. Chou KR, Chen R, Lee JF, et al. The effectiveness of nicotinepatch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud. 2004;41:321-30. (Pubitemid 38223990)
27. Evins AE, Mays VK, Rigotti NA, et al. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res. 2001;3:397-403. (Pubitemid 33101067)
28. Evins AE, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol. 2005;25:218-25. (Pubitemid 40685784)
29. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195-201.
30. George TP, Vessicchio JC, Termine A, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry. 2002;52:53-61. (Pubitemid 34655556)
31. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;16: CD006103.
32. Freedman R. Exacerbation of schizophrenia by varenicline. Am J Psychiatry. 2007;164:1269.
33. Popkin MK. Exacerbation of recurrent depression as a result of treatment with varenicline. Am J Psychiatry. 2008;165:774. (Pubitemid 351810551)
34. Williams JM, Anthenelli RM, Morris C, et al. A double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline tartrate for smoking cessation in schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2012;73:654-60.
35. Isensee B, Wittchen H, Stein MB, et al. Smoking increases the risk of panic: findings from a prospective community sample. Arch Gen Psychiatry. 2003;60:692-700. (Pubitemid 36818631)
36. Zvolensky MJ, Forsyth JP, Fuse T, et al. Smoking and non-clinical panic attacks: an initial empirical test of panic-relevant cognitive processes. Cog Behavior Therapy. 2002;31:170-82. (Pubitemid 36181631)
37. Ziedonis DM, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: national institute of mental health report. Nicotine Tob Res. 2008;10:1691-715.
38. Beckham JC, Roodman AA, Shipley RH, et al. Smoking in Vietnam combat veterans with post-traumatic stress disorder. J Trauma Stress. 1995;8:461-72.
39. Beckham JC, Kirby AC, Feldman ME, et al. Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addict Behav. 1997;22:637-47. (Pubitemid 27407442)
40. Op Den Velde W, Aarts PG, Falger PR, et al. Alcohol use, cigarette consumption, and chronic post-traumatic stress disorder. Alcohol Alcohol. 2002;37:355-61. (Pubitemid 34830914)
41. McFall M, Saxon AJ, Thompson CE, et al. Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry. 2005;162:1311-9. (Pubitemid 40905582)
42. Hertzberg MA, Moore SD, Feldman ME, et al. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic post-traumatic stress disorder. J Clin Psychopharmacol. 2001;21:94-8. (Pubitemid 32096757)
43. McFall M, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized clinical trial. JAMA. 2010;304:2485-93.
44. Prochaska JJ. Integrating tobacco treatment into mental health settings. JAMA. 2010;304:2534-5.
45. Acton GS, Prochaska JJ, Kaplan AA, et al. Depression and stages of change for smoking in psychiatric outpatients. Addict Behav. 2001;26:621-31. (Pubitemid 32826203)
46. Haug NA, Hall SM, Prochaska JJ, et al. Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine Tob Res. 2005;7:217-24. (Pubitemid 40852148)
47. Breslau N, Johnson EO. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health. 2000;90:1122-227.
48. Breslau N, Peterson EL, Schultz LR, et al. Major depression and stages of smoking. a longitudinal investigation. Arch Gen Psychiatry. 1998;55:161-6. (Pubitemid 28087602)
49. Weinberger AH, George TP, McKee SA. Differences in smoking expectancies in smokers with and without a history of major depression. Addict Behav. 2010;36:434-7.
50. Thorsteinsson HS, Gillin JC, Patten CA, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24:350-8. (Pubitemid 32157551)
51. Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmcol. 2008;28:660-6.
52. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;10:1808-14. (Pubitemid 44497738)
53. MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78:55-61.
54. Vickers KS, Patten CA, Lewis BA, et al. Feasibility of an exercise counseling intervention for depressed women smokers. Nicotine Tob Res. 2009;8:985-95.
55. Philip NS, Carpenter LL, Tyrka AR, et al. Varenicline augmentation in depressed smokers: an 8-week, open-label study. J Clin Psychiatry. 2009;70:1026-31.
56. Chengappa KNR, Kambhampati RK, Perkins K, et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants. J Clin Psychiatry. 2001;62:503-8. (Pubitemid 32703088)
57. Trockel M, Burg M, Jaffe A, et al. Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosom Med. 2008;70:875-82.
58. Weinberger AH, Vessicchio JC, Sacco KC, et al. A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. J Clin Psychopharmacol. 2008;28:584-7.
59. Wu BS, Weinberger AH, Mancuso E, et al. A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. J Dual Diagnosis. 2012;2:131-2.
60. Weinberger AH, Sofuoglu M. The impact of cigarette smoking on stimulant addiction. Am J Drug Alcohol Abuse. 2009;35:12-7.
61. Hays JT, Schroeder DR, Offord KP, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 1999;21:244-50.
62. Kalman D, Kahler CW, Garvey AJ, Monti PM. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes. J Subst Abuse Treat. 2006;30:213-7.
63. Kalman D, Herz L, Monti P, et al. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, doubleblind, placebo-controlled study. Drug Alcohol Depend. 2011;118:111-8.
64. Hays JT, Hurt RD, Decker PA, et al. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. Nicotine Tob Res. 2009;11:859-67.
65. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72:1144-56. (Pubitemid 39658547)
66. Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004;65:681-91. (Pubitemid 40096930)
67. Nieva G, Ortega LL, Mondona S. Simultaneous versus delayed treatment of tobacco dependence in alcohol-dependent outpatients. Eur Addict Res. 2010;17:1-9.
68. Hays JT, Croghan IT, Schroeder DR, et al. Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study. J Subst Abuse Treat. 2011;41:102-7.
69. McKee SA, Harrison ELR, O'Malley SS, et al. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry. 2009;66:185-90.
70. Nahvi S, Richter K, Li X, et al. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav. 2006;31:2127-34. (Pubitemid 44548179)
71. Poling J, Rounsaville B, Gonsai K, et al. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. Am J Addict. 2010;19:401-8.
72. Okoli CTC, Khara M, Procyshyn RM, et al. Smoking cessation interventions among individuals in methadone maintenance: a brief review. J Subst Abuse Treat. 2010;38:191-9.
73. Moss TG, Weinberger AH, Vessicchio JC, et al. A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. Am J Addict. 2010;19:293-311.
74. Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of 10-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80:45-53. (Pubitemid 41587462)
75. George TP, Ziedonis DM. Addressing tobacco dependence in psychiatric practice: promises and pitfalls. Can J Psychiatry. 2009;54:353-5.
76. George TP. Nicotine and tobacco. In: Goldman L, Schaffer A, editors. Cecil textbook of medicine. 24th ed. New York, NY: Elsevier; 2011. p. 2672.